Symbols / DGX Stock $189.81 +1.29% Quest Diagnostics Incorporated

Healthcare • Diagnostics & Research • United States • NYQ
DGX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. James E. Davis
Exch · Country NYQ · United States
Market Cap 21.01B
Enterprise Value 27.41B
Income 1.02B
Sales 11.28B
FCF (ttm) 947.88M
Book/sh 66.36
Cash/sh 3.55
Employees 57,000
Insider 10d —
IPO Dec 17, 1996
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 36.02%
P/E 20.97
Forward P/E 16.27
PEG 1.44
P/S 1.86
P/B 2.86
P/C —
EV/EBITDA 12.31
EV/Sales 2.43
Quick Ratio 0.91
Current Ratio 1.18
Debt/Eq 82.74
LT Debt/Eq —
EPS (ttm) 9.05
EPS next Y 11.67
EPS Growth 15.50%
Revenue Growth 9.20%
EPS Gr Q/Q 14.50%
Rev Gr Q/Q —
Earnings (next) 2026-07-21
Earnings (prior) 2026-04-21
ROA 6.35%
ROE 14.54%
ROIC —
Gross Margin 33.28%
Oper. Margin 14.20%
Profit Margin 9.08%
Shs Outstand 110.70M
Shs Float 110.08M
Insider Own 0.42%
Instit Own 104.55%
Short Float 3.22%
Short Ratio 4.12
Short Interest 3.55M
52W High 213.50
vs 52W High -11.10%
52W Low 164.65
vs 52W Low 15.28%
Beta 0.59
Impl. Vol. 0.20%
Rel Volume 0.55
Avg Volume 911.22K
Volume 498.22K
Target (mean) $223.25
Tgt Median $225.00
Tgt Low $184.00
Tgt High $245.00
# Analysts 16
Recom Buy
Prev Close $187.39
Price $189.81
Change 1.29%
About

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$223.25
Mean price target
2. Current target
$189.81
Latest analyst target
3. DCF / Fair value
$154.13
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$189.81
Low
$184.00
High
$245.00
Mean
$223.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-22 main UBS Neutral → Neutral $220
2026-04-22 main Baird Neutral → Neutral $229
2026-04-22 main Barclays Overweight → Overweight $230
2026-04-22 main Truist Securities Hold → Hold $225
2026-04-08 main Evercore ISI Group In-Line → In-Line $210
2026-02-12 main Mizuho Outperform → Outperform $235
2026-02-11 main Truist Securities Hold → Hold $220
2026-02-11 main UBS Neutral → Neutral $210
2026-02-11 main Evercore ISI Group In-Line → In-Line $220
2026-02-11 main Barclays Overweight → Overweight $225
2026-02-11 main Jefferies Buy → Buy $220
2026-02-10 main Citigroup Neutral → Neutral $215
2025-10-27 main Piper Sandler Neutral → Neutral $200
2025-10-22 main Barclays Equal-Weight → Equal-Weight $195
2025-10-22 main Truist Securities Hold → Hold $205
2025-10-21 main Leerink Partners Outperform → Outperform $210
2025-10-21 main Jefferies Buy → Buy $215
2025-10-17 main UBS Neutral → Neutral $190
2025-10-17 main Mizuho Outperform → Outperform $210
2025-10-08 main Evercore ISI Group In-Line → In-Line $190
News
RSS: Latest DGX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-20 SAMAD SAMER ABDUL Chief Financial Officer — 108 $194.70 $21,027
2026-04-20 LASSITER WRIGHT III Director — 6 $194.70 $1,168
2026-04-20 KUPPUSAMY KARTHIK Officer — 39 $194.70 $7,593
2026-04-20 DELANEY MARK E Officer — 37 $194.70 $7,204
2026-04-20 PLEWMAN PATRICK Officer — 49 $194.70 $9,540
2026-04-20 GREGG VICKY B Director — 68 $194.70 $13,239
2026-03-09 WENTWORTH TIMOTHY CHARLES Director — 215 $0.00 $0
2026-03-05 PLEWMAN PATRICK Officer — 2,855 $206.21 $588,730
2026-03-05 DOHERTY CATHERINE T Officer — 5,558 $206.21 $1,146,115
2026-03-05 PREVOZNIK MICHAEL E General Counsel — 3,878 $206.21 $799,682
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
11,035.00
+11.78%
9,872.00
+6.70%
9,252.00
-6.38%
9,883.00
Operating Revenue
11,035.00
+11.78%
9,872.00
+6.70%
9,252.00
-6.38%
9,883.00
Cost Of Revenue
7,370.00
+11.19%
6,628.00
+6.92%
6,199.00
-3.89%
6,450.00
Reconciled Cost Of Revenue
6,954.00
+11.05%
6,262.00
+6.71%
5,868.00
-4.32%
6,133.00
Gross Profit
3,665.00
+12.98%
3,244.00
+6.26%
3,053.00
-11.07%
3,433.00
Operating Expense
2,109.00
+11.12%
1,898.00
+5.97%
1,791.00
-10.67%
2,005.00
Selling General And Administration
1,967.00
+11.13%
1,770.00
+7.80%
1,642.00
-12.38%
1,874.00
Other Operating Expenses
-12.00
-1300.00%
1.00
-97.56%
41.00
+272.73%
11.00
Total Expenses
9,479.00
+11.18%
8,526.00
+6.71%
7,990.00
-5.50%
8,455.00
Operating Income
1,556.00
+15.60%
1,346.00
+6.66%
1,262.00
-11.62%
1,428.00
Total Operating Income As Reported
1,556.00
+15.60%
1,346.00
+6.66%
1,262.00
-11.62%
1,428.00
EBITDA
2,165.00
+14.31%
1,894.00
+9.35%
1,732.00
-4.84%
1,820.00
Normalized EBITDA
2,165.00
+14.31%
1,894.00
+9.35%
1,732.00
-4.84%
1,820.00
Reconciled Depreciation
570.00
+15.62%
493.00
+12.30%
439.00
+0.46%
437.00
EBIT
1,595.00
+13.85%
1,401.00
+8.35%
1,293.00
-6.51%
1,383.00
Net Income
992.00
+13.89%
871.00
+1.99%
854.00
-9.73%
946.00
Pretax Income
1,318.00
+12.17%
1,175.00
+3.98%
1,130.00
-8.50%
1,235.00
Net Non Operating Interest Income Expense
-264.00
-31.34%
-201.00
-32.24%
-152.00
-10.14%
-138.00
Interest Expense Non Operating
277.00
+22.57%
226.00
+38.65%
163.00
+10.14%
148.00
Net Interest Income
-264.00
-31.34%
-201.00
-32.24%
-152.00
-10.14%
-138.00
Interest Expense
277.00
+22.57%
226.00
+38.65%
163.00
+10.14%
148.00
Interest Income Non Operating
13.00
-48.00%
25.00
+127.27%
11.00
+10.00%
10.00
Interest Income
13.00
-48.00%
25.00
+127.27%
11.00
+10.00%
10.00
Other Income Expense
26.00
-13.33%
30.00
+50.00%
20.00
+136.36%
-55.00
Other Non Operating Income Expenses
26.00
-13.33%
30.00
+50.00%
20.00
+136.36%
-55.00
Tax Provision
314.00
+15.02%
273.00
+10.08%
248.00
-6.06%
264.00
Tax Rate For Calcs
0.00
+2.59%
0.00
+5.45%
0.00
+2.80%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1,046.00
+13.57%
921.00
+1.43%
908.00
-10.54%
1,015.00
Net Income From Continuing Operation Net Minority Interest
992.00
+13.89%
871.00
+1.99%
854.00
-9.73%
946.00
Net Income From Continuing And Discontinued Operation
992.00
+13.89%
871.00
+1.99%
854.00
-9.73%
946.00
Net Income Continuous Operations
1,046.00
+13.57%
921.00
+1.43%
908.00
-10.54%
1,015.00
Net Income Discontinuous Operations
—
—
—
—
Minority Interests
-54.00
-8.00%
-50.00
+7.41%
-54.00
+21.74%
-69.00
Normalized Income
992.00
+13.89%
871.00
+1.99%
854.00
-9.73%
946.00
Net Income Common Stockholders
988.00
+14.09%
866.00
+1.88%
850.00
-9.77%
942.00
Otherunder Preferred Stock Dividend
4.00
-20.00%
5.00
+25.00%
4.00
+0.00%
4.00
Diluted EPS
8.75
+13.78%
7.69
+2.67%
7.49
-6.02%
7.97
Basic EPS
8.87
+14.01%
7.78
+2.50%
7.59
-6.30%
8.10
Basic Average Shares
111.00
+0.00%
111.00
-0.89%
112.00
-3.45%
116.00
Diluted Average Shares
113.00
+0.00%
113.00
+0.00%
113.00
-4.24%
118.00
Diluted NI Availto Com Stockholders
988.00
+14.09%
866.00
+1.88%
850.00
-9.77%
942.00
Amortization
154.00
+21.26%
127.00
+17.59%
108.00
-10.00%
120.00
Amortization Of Intangibles Income Statement
154.00
+21.26%
127.00
+17.59%
108.00
-10.00%
120.00
Depreciation Amortization Depletion Income Statement
154.00
+21.26%
127.00
+17.59%
108.00
-10.00%
120.00
Depreciation And Amortization In Income Statement
154.00
+21.26%
127.00
+17.59%
108.00
-10.00%
120.00
Earnings From Equity Interest Net Of Tax
42.00
+121.05%
19.00
-26.92%
26.00
-40.91%
44.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
16,225.00
+0.45%
16,153.00
+15.20%
14,022.00
+9.23%
12,837.00
Current Assets
2,378.00
-0.59%
2,392.00
+0.84%
2,372.00
+24.97%
1,898.00
Cash Cash Equivalents And Short Term Investments
420.00
-23.50%
549.00
-19.97%
686.00
+117.78%
315.00
Cash And Cash Equivalents
420.00
-23.50%
549.00
-19.97%
686.00
+117.78%
315.00
Receivables
1,408.00
+7.98%
1,304.00
+7.77%
1,210.00
+1.26%
1,195.00
Accounts Receivable
1,408.00
+7.98%
1,304.00
+7.77%
1,210.00
+1.26%
1,195.00
Gross Accounts Receivable
1,433.00
+7.50%
1,333.00
+7.76%
1,237.00
+0.98%
1,225.00
Allowance For Doubtful Accounts Receivable
-25.00
+13.79%
-29.00
-7.41%
-27.00
+10.00%
-30.00
Inventory
189.00
+0.53%
188.00
-1.05%
190.00
-1.04%
192.00
Prepaid Assets
—
—
—
—
Other Current Assets
361.00
+2.85%
351.00
+22.73%
286.00
+45.92%
196.00
Net PPE
2,860.00
+3.47%
2,764.00
+14.31%
2,418.00
+2.85%
2,351.00
Gross PPE
6,833.00
+6.40%
6,422.00
+10.08%
5,834.00
+2.57%
5,688.00
Accumulated Depreciation
-3,973.00
-8.61%
-3,658.00
-7.08%
-3,416.00
-2.37%
-3,337.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
84.00
+3.70%
81.00
+102.50%
40.00
-6.98%
43.00
Buildings And Improvements
629.00
+3.11%
610.00
+18.91%
513.00
-1.35%
520.00
Machinery Furniture Equipment
4,317.00
+8.91%
3,964.00
+9.99%
3,604.00
+2.88%
3,503.00
Construction In Progress
252.00
+7.23%
235.00
-5.24%
248.00
-10.47%
277.00
Other Properties
657.00
+0.92%
651.00
+8.14%
602.00
+2.91%
585.00
Leases
894.00
+1.48%
881.00
+6.53%
827.00
+8.82%
760.00
Goodwill And Other Intangible Assets
10,581.00
-0.36%
10,619.00
+19.33%
8,899.00
+7.06%
8,312.00
Goodwill
8,945.00
+1.00%
8,856.00
+14.52%
7,733.00
+7.11%
7,220.00
Other Intangible Assets
1,636.00
-7.20%
1,763.00
+51.20%
1,166.00
+6.78%
1,092.00
Investments And Advances
136.00
+10.57%
123.00
-8.89%
135.00
+2.27%
132.00
Long Term Equity Investment
136.00
+10.57%
123.00
-8.89%
135.00
+2.27%
132.00
Other Non Current Assets
270.00
+5.88%
255.00
+28.79%
198.00
+37.50%
144.00
Total Liabilities Net Minority Interest
8,939.00
-3.44%
9,257.00
+21.74%
7,604.00
+11.33%
6,830.00
Current Liabilities
2,278.00
+5.03%
2,169.00
+19.50%
1,815.00
+17.02%
1,551.00
Payables And Accrued Expenses
1,397.00
+13.39%
1,232.00
+0.16%
1,230.00
-5.67%
1,304.00
Payables
465.00
+23.67%
376.00
-18.61%
462.00
+9.22%
423.00
Accounts Payable
307.00
+6.97%
287.00
-24.07%
378.00
+16.67%
324.00
Other Payable
51.00
+920.00%
5.00
+0.00%
5.00
-78.26%
23.00
Dividends Payable
89.00
+5.95%
84.00
+6.33%
79.00
+6.76%
74.00
Current Accrued Expenses
932.00
+8.88%
856.00
+11.46%
768.00
-12.83%
881.00
Total Tax Payable
18.00
0.00
0.00
-100.00%
2.00
Income Tax Payable
18.00
0.00
0.00
-100.00%
2.00
Current Debt And Capital Lease Obligation
881.00
-5.98%
937.00
+60.17%
585.00
+136.84%
247.00
Current Debt
707.00
-7.46%
764.00
+76.85%
432.00
+359.57%
94.00
Other Current Borrowings
504.00
-16.28%
602.00
+98.68%
303.00
+15050.00%
2.00
Current Capital Lease Obligation
174.00
+0.58%
173.00
+13.07%
153.00
+0.00%
153.00
Total Non Current Liabilities Net Minority Interest
6,661.00
-6.02%
7,088.00
+22.44%
5,789.00
+9.66%
5,279.00
Long Term Debt And Capital Lease Obligation
5,704.00
-7.25%
6,150.00
+25.18%
4,913.00
+9.98%
4,467.00
Long Term Debt
5,167.00
-7.98%
5,615.00
+27.32%
4,410.00
+10.86%
3,978.00
Long Term Capital Lease Obligation
537.00
+0.37%
535.00
+6.36%
503.00
+2.86%
489.00
Other Non Current Liabilities
957.00
+2.03%
938.00
+7.08%
876.00
+7.88%
812.00
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
7,170.00
+5.78%
6,778.00
+7.47%
6,307.00
+7.03%
5,893.00
Common Stock Equity
7,170.00
+5.78%
6,778.00
+7.47%
6,307.00
+7.03%
5,893.00
Capital Stock
2.00
+0.00%
2.00
+0.00%
2.00
+0.00%
2.00
Common Stock
2.00
+0.00%
2.00
+0.00%
2.00
+0.00%
2.00
Share Issued
162.24
+0.39%
161.62
-0.50%
162.43
+0.27%
162.00
Ordinary Shares Number
110.24
-0.34%
110.62
-0.74%
111.43
+0.39%
111.00
Treasury Shares Number
52.00
+1.96%
51.00
+0.00%
51.00
+0.00%
51.00
Additional Paid In Capital
2,381.00
+0.85%
2,361.00
+1.77%
2,320.00
+1.09%
2,295.00
Retained Earnings
9,994.00
+6.77%
9,360.00
+6.06%
8,825.00
+6.45%
8,290.00
Gains Losses Not Affecting Retained Earnings
-27.00
+69.32%
-88.00
-528.57%
-14.00
+33.33%
-21.00
Treasury Stock
5,180.00
+6.65%
4,857.00
+0.64%
4,826.00
+3.27%
4,673.00
Minority Interest
116.00
-1.69%
118.00
+6.31%
111.00
-2.63%
114.00
Other Equity Adjustments
-27.00
+69.32%
-88.00
-528.57%
-14.00
+33.33%
-21.00
Total Equity Gross Minority Interest
7,286.00
+5.66%
6,896.00
+7.45%
6,418.00
+6.84%
6,007.00
Total Capitalization
12,337.00
-0.45%
12,393.00
+15.64%
10,717.00
+8.57%
9,871.00
Working Capital
100.00
-55.16%
223.00
-59.96%
557.00
+60.52%
347.00
Invested Capital
13,044.00
-0.86%
13,157.00
+18.01%
11,149.00
+11.88%
9,965.00
Total Debt
6,585.00
-7.08%
7,087.00
+28.90%
5,498.00
+16.63%
4,714.00
Net Debt
5,454.00
-6.45%
5,830.00
+40.28%
4,156.00
+10.62%
3,757.00
Capital Lease Obligations
711.00
+0.42%
708.00
+7.93%
656.00
+2.18%
642.00
Net Tangible Assets
-3,411.00
+11.20%
-3,841.00
-48.19%
-2,592.00
-7.15%
-2,419.00
Tangible Book Value
-3,411.00
+11.20%
-3,841.00
-48.19%
-2,592.00
-7.15%
-2,419.00
Interest Payable
25.00
-19.35%
31.00
-51.56%
64.00
+146.15%
26.00
Line Of Credit
203.00
+25.31%
162.00
+25.58%
129.00
+40.22%
92.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,886.00
+41.38%
1,334.00
+4.87%
1,272.00
-25.96%
1,718.00
Cash Flow From Continuing Operating Activities
1,886.00
+41.38%
1,334.00
+4.87%
1,272.00
-25.96%
1,718.00
Net Income From Continuing Operations
1,046.00
+13.57%
921.00
+1.43%
908.00
-10.54%
1,015.00
Depreciation Amortization Depletion
570.00
+15.62%
493.00
+12.30%
439.00
+0.46%
437.00
Depreciation
416.00
+13.66%
366.00
+10.57%
331.00
+4.42%
317.00
Amortization Cash Flow
154.00
+21.26%
127.00
+17.59%
108.00
-10.00%
120.00
Depreciation And Amortization
570.00
+15.62%
493.00
+12.30%
439.00
+0.46%
437.00
Amortization Of Intangibles
154.00
+21.26%
127.00
+17.59%
108.00
-10.00%
120.00
Other Non Cash Items
24.00
+60.00%
15.00
-63.41%
41.00
-37.88%
66.00
Stock Based Compensation
88.00
+0.00%
88.00
+14.29%
77.00
+0.00%
77.00
Provisionand Write Offof Assets
3.00
-40.00%
5.00
+400.00%
1.00
-66.67%
3.00
Deferred Tax
105.00
+707.69%
13.00
+126.53%
-49.00
-5000.00%
1.00
Deferred Income Tax
105.00
+707.69%
13.00
+126.53%
-49.00
-5000.00%
1.00
Operating Gains Losses
—
—
—
—
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
50.00
+124.88%
-201.00
-38.62%
-145.00
-221.85%
119.00
Change In Receivables
-106.00
-49.30%
-71.00
-373.33%
-15.00
-106.10%
246.00
Changes In Account Receivables
-106.00
-49.30%
-71.00
-373.33%
-15.00
-106.10%
246.00
Change In Payables And Accrued Expense
153.00
+400.00%
-51.00
+10.53%
-57.00
+68.33%
-180.00
Change In Payable
153.00
+400.00%
-51.00
+10.53%
-57.00
+68.33%
-180.00
Change In Account Payable
129.00
+292.54%
-67.00
-21.82%
-55.00
+63.09%
-149.00
Change In Other Working Capital
3.00
+103.80%
-79.00
-8.22%
-73.00
-237.74%
53.00
Investing Cash Flow
-631.00
+75.24%
-2,548.00
-140.15%
-1,061.00
-95.40%
-543.00
Cash Flow From Continuing Investing Activities
-631.00
+75.24%
-2,548.00
-140.15%
-1,061.00
-95.40%
-543.00
Net PPE Purchase And Sale
—
—
—
—
Sale Of PPE
—
—
—
—
Capital Expenditure
-527.00
-24.00%
-425.00
-4.17%
-408.00
-0.99%
-404.00
Capital Expenditure Reported
-527.00
-24.00%
-425.00
-4.17%
-408.00
-0.99%
-404.00
Net Investment Purchase And Sale
—
—
-42.00
-940.00%
5.00
Purchase Of Investment
—
—
—
—
Sale Of Investment
—
—
—
5.00
Net Business Purchase And Sale
-101.00
+95.33%
-2,164.00
-254.17%
-611.00
-324.31%
-144.00
Purchase Of Business
-101.00
+95.33%
-2,164.00
-254.17%
-611.00
-324.31%
-144.00
Gain Loss On Sale Of Business
—
—
0.00
0.00
Net Other Investing Changes
-3.00
-107.32%
41.00
+197.62%
-42.00
-940.00%
5.00
Financing Cash Flow
-1,388.00
-228.04%
1,084.00
+577.50%
160.00
+109.24%
-1,732.00
Cash Flow From Continuing Financing Activities
-1,388.00
-228.04%
1,084.00
+577.50%
160.00
+109.24%
-1,732.00
Net Issuance Payments Of Debt
-602.00
-139.01%
1,543.00
+106.28%
748.00
+37500.00%
-2.00
Issuance Of Debt
410.00
-77.79%
1,846.00
-28.78%
2,592.00
0.00
Repayment Of Debt
-1,012.00
-233.99%
-303.00
+83.57%
-1,844.00
-92100.00%
-2.00
Long Term Debt Issuance
410.00
-77.79%
1,846.00
-28.78%
2,592.00
0.00
Long Term Debt Payments
-1,012.00
-233.99%
-303.00
+83.57%
-1,844.00
-92100.00%
-2.00
Net Long Term Debt Issuance
-602.00
-139.01%
1,543.00
+106.28%
748.00
+37500.00%
-2.00
Net Common Stock Issuance
-450.00
-198.01%
-151.00
+45.09%
-275.00
+80.47%
-1,408.00
Common Stock Payments
-450.00
-198.01%
-151.00
+45.09%
-275.00
+80.47%
-1,408.00
Common Stock Dividend Paid
-353.00
-6.65%
-331.00
-5.41%
-314.00
-2.95%
-305.00
Cash Dividends Paid
-353.00
-6.65%
-331.00
-5.41%
-314.00
-2.95%
-305.00
Repurchase Of Capital Stock
-450.00
-198.01%
-151.00
+45.09%
-275.00
+80.47%
-1,408.00
Proceeds From Stock Option Exercised
79.00
+8.22%
73.00
+1.39%
72.00
-41.46%
123.00
Net Other Financing Charges
-62.00
-24.00%
-50.00
+29.58%
-71.00
+49.29%
-140.00
Changes In Cash
-133.00
-2.31%
-130.00
-135.04%
371.00
+166.61%
-557.00
Effect Of Exchange Rate Changes
4.00
+157.14%
-7.00
0.00
0.00
Beginning Cash Position
549.00
-19.97%
686.00
+117.78%
315.00
-63.88%
872.00
End Cash Position
420.00
-23.50%
549.00
-19.97%
686.00
+117.78%
315.00
Free Cash Flow
1,359.00
+49.50%
909.00
+5.21%
864.00
-34.25%
1,314.00
Interest Paid Supplemental Data
280.00
+6.87%
262.00
+95.52%
134.00
-14.10%
156.00
Income Tax Paid Supplemental Data
169.00
-33.98%
256.00
-19.24%
317.00
+12.01%
283.00
Change In Income Tax Payable
24.00
+50.00%
16.00
+900.00%
-2.00
+93.55%
-31.00
Change In Tax Payable
24.00
+50.00%
16.00
+900.00%
-2.00
+93.55%
-31.00
Sale Of Business
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category